| Gene editing to induce FOXP3 expression in human CD4+ T cells leads to a stable regulatory phenotype and function Y Honaker, N Hubbard, Y Xiang, L Fisher, D Hagin, K Sommer, Y Song, ... Science translational medicine 12 (546), eaay6422, 2020 | 89 | 2020 |
| Pancreatic islet-specific engineered Tregs exhibit robust antigen-specific and bystander immune suppression in type 1 diabetes models SJ Yang, AK Singh, T Drow, T Tappen, Y Honaker, ... Science Translational Medicine 14 (665), eabn1716, 2022 | 32 | 2022 |
| Generation of islet antigen-specific engineered Tregs for use in T1D therapy via homology-directed gene editing of conventional CD4+ T cells SJ Yang, AK Singh, T Tappen, Y Honaker, K Mauk, J Smith, K Sommer, ... The Journal of Immunology 206 (1_Supplement), 18.13-18.13, 2021 | 3 | 2021 |
| Generation of islet antigen-specific engineered Treg for use in T1D therapy via homology-directed gene editing of conventional CD4+ T cells SJ Yang, A Singh, P Cook, Y Honaker, T Tappen, K Mauk, J Smith, ... The Journal of Immunology 204 (1_Supplement), 237.30-237.30, 2020 | 2 | 2020 |
| The role of bystander activation among CD8αα T cells in controlling Mycobacterium tuberculosisinfection CR Winter, A Zhou, T Tappen, H Ou, C Seshadri The Journal of Immunology 210 (1_Supplement), 226.03-226.03, 2023 | | 2023 |
| Generation of Islet-Specific Gene-Edited Regulatory T Cells (edT (reg)) for Restoration of Immune Tolerance in Type 1 Diabetes PJ Cook, A Singh, SJ Yang, Y Honaker, T Tappen, JM Smith, S Patel, ... MOLECULAR THERAPY 28 (4), 391-392, 2020 | | 2020 |
